Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers

NCT06995482 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Postmenopausal Women

Interventions

DRUG: KSHN001034
DRUG: KSHN001034
DRUG: KSHN001034
DRUG: KSHN001034
DRUG: KSHN001034
DRUG: Fulvestrant

Sponsor

Kashiv BioSciences, LLC

Collaborators

[object Object]
[object Object]